This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kerr DJ et al. (2003) Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet 361: 368–373
Hurwitz H et al. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335–2342
Grothey A et al. (2004) Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-FA, irinotecan and oxaliplatin in the course of treatment. J Clin Oncol 22: 1209–1214
Kemeny N et al. (2005) Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 23: 4888–4896
Acknowledgements
The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Kerr, D. Does chemotherapy given directly to the liver improve survival in patients with hepatic metastasis?. Nat Rev Clin Oncol 3, 480–481 (2006). https://doi.org/10.1038/ncponc0566
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0566